Skip to main content
ASARFI HOSPITAL LIMITED logo

ASARFI HOSPITAL LIMITED — Investor Relations & Filings

Ticker · 543943 ISIN · INE0DN001027 LEI · 984500678B2D811D4E74 BSE.NS Human health and social work activities
Open in API
Filings indexed 117 across all filing types
Latest filing 2026-05-21 Regulatory Filings
Country IN India
Listing BSE.NS 543943

About ASARFI HOSPITAL LIMITED

https://www.asarfi.in

Asarfi Hospital Limited is a multi-specialty healthcare facility providing comprehensive medical services. The institution offers specialized care in departments such as cardiology, oncology, orthopedics, nephrology, and gastroenterology. Its infrastructure includes advanced diagnostic imaging, surgical suites, intensive care units, and emergency medical services. The facility is equipped to handle complex medical procedures and provides integrated services including pharmacy, pathology, and radiology. With a focus on patient-centric care, the hospital utilizes modern medical technology and a multidisciplinary team of healthcare professionals to deliver diagnostic, therapeutic, and rehabilitative services.

Recent filings

Filing Released Lang Actions
With reference to our earlier intimation regarding the Analyst / Investor Meeting scheduled to be held on Monday, May 25, 2026, at 04:00 P.M. (IST), we wish to inform you that due to unavoidable ....
Regulatory Filings Classification · 85% confidence The document is a formal disclosure to BSE under SEBI LODR Regulation 30 announcing the rescheduling of an analyst/investor meeting (conference call) to discuss the audited Q4 & FY 2025-26 results. It contains no financial statements or earnings highlights itself and is not an actual report, transcript, or presentation but rather a regulatory notice of the call. This falls under the general Regulatory Filings category (RNS).
2026-05-21 English
We wish to inform you that the Company has scheduled a Conference Call with Analysts / Investors on Monday, May 25, 2026 at 04:00 P.M. (IST), inter alia, to discuss the Audited Financial ....
Regulatory Filings Classification · 85% confidence The document is a SEBI Reg. 30 disclosure to BSE announcing the schedule for an analyst/investor conference call to discuss audited quarterly and year‐end results. It does not contain financial data itself (so it’s not an earnings release or interim report), nor is it a transcript or presentation. It is a regulatory announcement under listing obligations, fitting the general Regulatory Filings category.
2026-05-20 English
We herewith a press release titled Extract of Audited Standalone and Consolidated financial Results of the Quarter and Year Ended March''31,2026 for your kind information and record.
Earnings Release Classification · 90% confidence The document is a press release issued under SEBI LODR Regulation 30 announcing the extract of audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. It contains key highlights (revenue, EBITDA, PAT, margins) and summary tables, but not the full report. This matches the definition of an Earnings Release (initial announcement of periodical financial results), rather than a full annual or interim report or other announcement type. FY 2026
2026-05-12 English
We herewith a press release titled Extract of Audited Standalone and Consolidated financial Results of the Quarter and Year Ended March''31,2026 for your kind information and record.
Earnings Release Classification · 88% confidence The document is a press/media release under SEBI LODR Regulation 30 summarizing and announcing the company’s audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. It contains key highlights and extracted financial figures rather than the full statutory report, fitting the definition of an Earnings Release (initial announcement of periodic financial results). FY 2026
2026-05-12 English
Intimation under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulation 15 - Press Release Titled Extract of Audited Standalone and Consolidated Financial Results ....
Earnings Release Classification · 85% confidence The document is a press release filed under SEBI LODR Regulation 30 / 33 announcing “Extract of audited Standalone and Consolidated Financial Results for the Quarter and Year Ended March 31, 2026.” It contains summary financial highlights and an extract of key line items from the audited results. It is an initial announcement of quarterly/annual financial results, not a full annual report or complete interim report, nor just a publication notice. This matches the Earnings Release category. FY 2026
2026-05-11 English
Investor Presentation of Asarfi Hospital Limited for the Quarter and Financial Year ended 31st March, 2026.
Investor Presentation Classification · 95% confidence The document is an investor presentation filed under Regulation 30 of SEBI LODR, containing slide content with quarterly and annual financial highlights, charts, and strategic commentary, not a brief factsheet or an earnings release. It is a detailed presentation prepared for investors. Therefore, it should be classified as an Investor Presentation (IP).
2026-05-11 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.